drugset / Trial / NCT00311051

Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite

NCT00311051

Phase 2/3 Withdrawn Research Center Borstel
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to examine wether the combination of Ramatroban/Montelukast is as effective as Montelukast alone in patients with mild to moderate atopic asthma (GINA I and II) sensitive to house dust mite. The test is performed by a specific inhalative provocation.

Timeline

Start
2005-04
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramatroban Small molecule
Background Montelukast Other / unclassified

Indications